Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial

We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Merck & Co., Inc. (NYSE:MRK) is one of the top performers on Tuesday. Shares of Merck & Co. Inc. (NYSE:MRK) rallied for a third straight day on Tuesday, as investors snapped up shares on twin catalysts, including tariffs on pharmaceutical imports and stellar results from its clinical trial for a treatment candidate for pulmonary arterial hypertension (PAH). During the session, Merck & Co., Inc. (NYSE:MRK) finished the day up by 6.8 ...